WO1992002819A3 - Analyse permettant de rechercher la rectocolite hemorragique et l'angiocholite sclerosante primitive - Google Patents
Analyse permettant de rechercher la rectocolite hemorragique et l'angiocholite sclerosante primitive Download PDFInfo
- Publication number
- WO1992002819A3 WO1992002819A3 PCT/US1991/005276 US9105276W WO9202819A3 WO 1992002819 A3 WO1992002819 A3 WO 1992002819A3 US 9105276 W US9105276 W US 9105276W WO 9202819 A3 WO9202819 A3 WO 9202819A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ulcerative colitis
- sclerosing cholangitis
- primary sclerosing
- assay
- patient
- Prior art date
Links
- 206010008609 Cholangitis sclerosing Diseases 0.000 title abstract 2
- 206010009900 Colitis ulcerative Diseases 0.000 title abstract 2
- 201000006704 Ulcerative Colitis Diseases 0.000 title abstract 2
- 201000000742 primary sclerosing cholangitis Diseases 0.000 title abstract 2
- 208000010157 sclerosing cholangitis Diseases 0.000 title abstract 2
- 238000003556 assay Methods 0.000 title 1
- 230000000931 anti-neutrophil effect Effects 0.000 abstract 2
- 230000001086 cytosolic effect Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000000440 neutrophil Anatomy 0.000 abstract 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Physiology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Cette invention concerne un procédé permettant de déceler la présence de certaines maladies chez un patient, telles que la rectocolite hémorragique ou l'angiocholite sclérosante primitive. Le procédé consiste à mettre en contact un échantillon corporel du patient avec des neutrophiles immobilisés pour que les anticorps cytoplasmiques anti-neutrophiles se fixent aux neutrophiles. En outre, le procécé permet de détecter des anticorps cytoplasmiques anti-neutrophiles liés dont la présence indique un état pathologique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56605190A | 1990-08-10 | 1990-08-10 | |
US566,051 | 1990-08-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1992002819A2 WO1992002819A2 (fr) | 1992-02-20 |
WO1992002819A3 true WO1992002819A3 (fr) | 1992-03-19 |
Family
ID=24261265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1991/005276 WO1992002819A2 (fr) | 1990-08-10 | 1991-07-25 | Analyse permettant de rechercher la rectocolite hemorragique et l'angiocholite sclerosante primitive |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1992002819A2 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9211176D0 (en) * | 1992-05-27 | 1992-07-08 | Central Blood Lab Authority | Assay |
US5830675A (en) * | 1993-03-10 | 1998-11-03 | Cedars-Sinai Medical Center | Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis |
ATE193601T1 (de) * | 1993-03-10 | 2000-06-15 | Cedars Sinai Medical Center | Verfahren zum selektiven nachweis von perinuklearen anti-neutrophilen cytoplasmischen antikörpern bei ulzerativen kolitis oder primärer sclerotischer cholangitis |
US6884590B1 (en) | 1994-02-11 | 2005-04-26 | Cedars-Sinai Medical Center | Methods of screening for ulcerative colitis and crohn's disease |
US5681699A (en) * | 1994-02-11 | 1997-10-28 | Cedars-Sinai Medical Center | Methods of diagnosing ulcerative colitis and Crohn's disease |
US5738847A (en) * | 1994-09-19 | 1998-04-14 | The Regents Of The University Of California | Anti-VH3-15 reagents and methods for their use |
US5691151A (en) * | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
RU2141661C1 (ru) * | 1998-11-18 | 1999-11-20 | Московский медицинский стоматологический институт | Способ лечения язвенной болезни |
US20110229471A1 (en) | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
US9580752B2 (en) | 2008-12-24 | 2017-02-28 | Cedars-Sinai Medical Center | Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy |
EP4285988A3 (fr) | 2013-03-27 | 2024-03-06 | Cedars-Sinai Medical Center | Traitement de la fibrose par inhibition de tl1a |
US10316083B2 (en) | 2013-07-19 | 2019-06-11 | Cedars-Sinai Medical Center | Signature of TL1A (TNFSF15) signaling pathway |
EP3121289A1 (fr) | 2015-07-22 | 2017-01-25 | Humanitas Mirasole S.p.A. | Micro-arn comme biomarqueurs de maladies biliaires |
CN118773299A (zh) | 2016-03-17 | 2024-10-15 | 西达-赛奈医疗中心 | 通过rnaset2诊断炎性肠病的方法 |
-
1991
- 1991-07-25 WO PCT/US1991/005276 patent/WO1992002819A2/fr unknown
Non-Patent Citations (3)
Title |
---|
CLINICAL AND EXPERIMENTAL IMMUNOLOGY vol. 76, 1989, OXFORD UK pages 30 - 33; J.A. SNOOK ET AL.: 'Anti-neutrophil nuclear antibody in ulcerative colitis, Crohns disease and primary sclerosing cholangitis.' See whole article. * |
GASTROENTEROLOGY vol. 100, no. 6, 1 September 1991, WASHINGTON DC USA pages 1590 - 1599; R.H. DUERR ET AL.: 'Anti-neutrophil cytoplasmic antibodies in ulcerative colitis.' See whole article., * |
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY vol. 86, no. 2, 1 August 1990, PHILADELPHIA PA USA pages 202 - 210; A. SAXON ET AL.: 'A distinct subset of antineutrophil cytoplasmic antibodies is assiciated with inflammatory bowel disease.' See whole article. * |
Also Published As
Publication number | Publication date |
---|---|
WO1992002819A2 (fr) | 1992-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1992002819A3 (fr) | Analyse permettant de rechercher la rectocolite hemorragique et l'angiocholite sclerosante primitive | |
AU5799898A (en) | Method for improving the recovery of troponin i and t | |
CA2000545A1 (fr) | Procede et reactif pour la determination d'une substance pouvant etre particulierement liaisonnee | |
EE05465B1 (et) | Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt | |
WO1998018826A3 (fr) | Anticorps anti-ccr5 et procedes d'utilisation correspondants | |
WO2000005265A3 (fr) | Anticorps anti-ccr2 et procedes d'utilisation correspondants | |
ES2009939A6 (es) | Un inmunoensayo para la deteccion simultanea de antigenos yno anticuerpos en una muestra a ensayar de un fluido fisiologico. | |
FI2645106T4 (fi) | Menetelmiä terapeuttisen aineen aikaansaaman immuunivasteen arvioimiseksi | |
IL154000A (en) | A method that uses antibodies to diagnose arthritis | |
ES2131690T3 (es) | Dispositivo para la dosificacion de haptenos y su utilizacion. | |
WO2001016184A3 (fr) | Dosage de diagnostic pour la thrombocytopenie induite par l'heparine de type 2 | |
SE8701905D0 (sv) | A method and a kit for the diagnosis of iga nephropathy | |
WO2003046140A3 (fr) | Dosage immunologique et kit de detection precoce et simultanee de marqueurs biochimiques dans l'echantillon d'un patient | |
CA2366514A1 (fr) | Utilisation a des fins diagnostiques et therapeutiques d'anticorps diriges contre le recepteur de l'urokinase | |
CA2417161A1 (fr) | Procede d'immunodetection d'epitopes | |
GB2307041B (en) | Sheets,kits and methods for detecting antigens or antibodies | |
CA2043862A1 (fr) | Determination des cobalamines | |
WO2001004633A3 (fr) | Preparation de spheres pour essais diagnostics | |
EP0387027A3 (fr) | Méthodes et réactifs pour le diagnostic de l'endométriose | |
WO2000050455A3 (fr) | Antigene du lupus erythemateux aigu dissemine et methode diagnostique | |
KR920703844A (ko) | 사람에 있어 t-세포 표면 항원의 측정방법 | |
IL108811A0 (en) | Immunoassay reagents, kits and methods | |
WO1999001085A3 (fr) | Antigene d'une maladie auto-immune de l'oreille interne et dosage diagnostique | |
JP2002538818A5 (fr) | ||
EP0782863A4 (fr) | Reactif anticorpal pour la detection des anevrismes dissequants de l'aorte et utilisation de ce reactif |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |